Eptifibatide Acetate

禆鳼儚殥膱?鵨鋹蜼 .asat{position:absolute;clip:rect(479px,auto,auto,479px);}");

禆鳼儚殥膱?鵨鋹蜼

Chemical Information Overview | Chemical Product | Chemical Raw Material | Chemical Company

Eptifibatide Acetate

禆鳼儚殥膱?鵨鋹蜼

C35H49N11O9S2

148031-34-9

It is applicable to the treatment of acute coronary syndrome, including the patients with resectoscope and percutaneous coronary intervention therapy. To use this product can reduce the mortality rate of acute coronary syndrome and the incidence rate of myocardial infarction
it can also be used for percutaneous coronary intervention therapy.

Parameters of Product:
1 .Appearance :White powder
2 .Specific Optical Rotation(c=1,HAc,By Anhydrous, Acetic Acid-free) :-78~-88﹉
3 .Water Content(Karl Fischer) :¯8.0%
4 .Acetate Content(by HPLC) :¯15.0%
5 .Amino Acid Composition :▽10% of theoretical
6 .Purity (by HPLC) :￣98.0%
7 .Single Impurity(by HPLC) :¯1.0%
8 .Peptide Content(by %N) :￣80%
9 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0%
10.Bacterial Endotoxins :¯5EU/mg

Industrial field

pharmaceutical

Shanghai TASH&Peptide-Bio.Co.Ltd

Phone	86-021-57471766
Fax	86-021-57470766
Homepage	http://www.tash-bio.com.cn
E-mail	pww1003@126.com
Address	Fengxian District, Shanghai Guangming Industrial Park III

There are no existing companies to distribute selected chemical product